Skip to content

Improvement of Hemostasis Techniques After Median Sternotomy

Improvement of Hemostasis Techniques After Median Sternotomy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01134471
Enrollment
75
Registered
2010-06-02
Start date
2009-04-30
Completion date
2011-05-31
Last updated
2010-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sternal Dehiscence, Sternal Infection, Sternal Pain

Brief summary

The purpose of this study is to compare 2 different hemostatic agents (Bonewax and Ostene)to a control group with regards to bleeding, bone healing, pain and infection in a patient group all undergoing median sternotomy.

Interventions

DEVICEOstene

applied to sternal surface

DEVICEBonewax

applied to sternal surface

Sponsors

Ceremed, Inc.
CollaboratorINDUSTRY
Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
60 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* men undergoing elective cardiac surgery at the Cardiac surgery department of Aarhus University Hospital, Skejby * no clopidogrel-treatment * no osteoporoses * less than 2 co-morbidities in the form of obesity (BMI\>30), COPD, chronic steroid use, renal failure, immunosuppression and diabetes

Exclusion criteria

* profuse sternal bleeding * serious complications to the surgery fx cerebral infarction * re-operation due to bleeding

Design outcomes

Primary

MeasureTime frame
Bone healing in sternum6 months after surgery
Questionnaire regarding physical and emotional well being6 months after surgery
Pain-score (VAS)6 months

Secondary

MeasureTime frame
Blood product consumption6 months
Bleeding through the chest tube6 months
Mediastinitis6 months
superficial infection6 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026